A novel biomarker Linc00974 interacting with KRT19 promotes proliferation and metastasis in hepatocellular carcinoma.
about
Crosstalk between Long Noncoding RNAs and MicroRNAs in Health and DiseaseCompeting endogenous RNA networks in human cancer: hypothesis, validation, and perspectivesLong noncoding RNAs in hepatocellular carcinoma: Novel insights into their mechanismCirculating lncRNAs associated with occurrence of colorectal cancer progression.LncRNA NALT interaction with NOTCH1 promoted cell proliferation in pediatric T cell acute lymphoblastic leukemia.Long non-coding RNA TUG1 is up-regulated in hepatocellular carcinoma and promotes cell growth and apoptosis by epigenetically silencing of KLF2Long noncoding RNA lncTCF7, induced by IL-6/STAT3 transactivation, promotes hepatocellular carcinoma aggressiveness through epithelial-mesenchymal transitionWT1-AS promotes cell apoptosis in hepatocellular carcinoma through down-regulating of WT1Linc00152 promotes proliferation in gastric cancer through the EGFR-dependent pathwayHsa-mir-1269 genetic variant contributes to hepatocellular carcinoma susceptibility through affecting SOX6.Linc-POU3F3 promotes cell proliferation in gastric cancer via increasing T-reg distribution.LINC00152 promotes proliferation in hepatocellular carcinoma by targeting EpCAM via the mTOR signaling pathwayThe Emerging Function and Mechanism of ceRNAs in Cancer.LINC01225 promotes occurrence and metastasis of hepatocellular carcinoma in an epidermal growth factor receptor-dependent pathway.Circulating MiRNA biomarkers serve as a fingerprint for diabetic atherosclerosisC-reactive protein levels in the perioperative period as a predictive marker of endoscopic recurrence after ileo-colonic resection for Crohn's disease.STARD13-correlated ceRNA network inhibits EMT and metastasis of breast cancer.PIK3C2A mRNA functions as a miR-124 sponge to facilitate CD151 expression and enhance malignancy of hepatocellular carcinoma cells.rs35301225 polymorphism in miR-34a promotes development of human colon cancer by deregulation of 3'UTR in E2F1 in Chinese population.miR-26a induced the suppression of tumor growth of cholangiocarcinoma via KRT19 approach.Identification of module biomarkers from the dysregulated ceRNA-ceRNA interaction network in lung adenocarcinoma.ceRNA in cancer: possible functions and clinical implications.The long noncoding RNA FOXCUT promotes proliferation and migration by targeting FOXC1 in nasopharyngeal carcinoma.Long noncoding RNA ENST00000434223 suppressed tumor progression in non-small cell lung cancer.A novel long noncoding RNA-LOWEG is low expressed in gastric cancer and acts as a tumor suppressor by inhibiting cell invasion.Function analysis of rs9589207 polymorphism in miR-92a in gastric cancer.LncRNA as a Therapeutic Target for Angiogenesis.Circulating microRNAs and extracellular vesicles as potential cancer biomarkers: a systematic review.The long non-coding RNA, SNHG6-003, functions as a competing endogenous RNA to promote the progression of hepatocellular carcinoma.Long noncoding RNA linc00617 exhibits oncogenic activity in breast cancer.The long noncoding RNA lnc-EGFR stimulates T-regulatory cells differentiation thus promoting hepatocellular carcinoma immune evasion.Long Noncoding RNAs Act as Novel Biomarkers for Hepatocellular Carcinoma: Progress and Prospects.Crosstalk between the Notch signaling pathway and non-coding RNAs in gastrointestinal cancers.Long Noncoding RNAs as a Key Player in Hepatocellular Carcinoma.A RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer.Therapeutic targeting of noncoding RNAs in hepatocellular carcinoma: Recent progress and future prospects.Methylene Tetrahydrofolate Reductase (MTHFR) rs868014 Polymorphism Regulated by miR-1203 Associates with Risk and Short Term Outcome of Ischemic Stroke.The plasma lncRNA acting as fingerprint in non-small-cell lung cancer.Silencing of long non-coding RNA MIR22HG triggers cell survival/death signaling via oncogenes YBX1, MET, and p21 in lung cancer.Identification of a microRNA signature associated with survivability in cervical squamous cell carcinoma.
P2860
Q26765464-439B29DD-50DE-42C3-B23E-1C592EB82530Q26766245-6EA6702D-942E-4878-ADF1-A63027E8025DQ26775818-3797D190-374E-4657-B3F5-56982C06E8EDQ35993148-8A041F55-48B4-4F6A-9EB7-D0D80B788D0BQ36018337-D3B4B657-4F67-4C5D-B628-4686A536E7ABQ36023541-5544FACF-2AEA-4AA4-BA96-0513C58EC633Q36144048-8B111FAE-4FC5-4802-89E8-75D208D69CD8Q36159699-B9E6C86D-4DD5-409C-BECF-5AD568337F80Q36246352-A49BBD17-A8D3-4DD1-A507-395CD51002BCQ36309552-6D3E3250-3EE6-490A-ADEA-4463E16B4C2DQ36420239-92F9B482-FD92-4C4D-9D9F-2A3ECBCB120DQ36619028-56AB8B59-C0F3-4A30-BE5E-B9D72ECA9ACFQ36723203-12872F17-3A29-451F-9A98-E2BE69DD76C9Q36774942-A1965391-840F-4284-8165-82D929EF1818Q37060780-9A644A23-F96F-40DB-A5ED-B6976D3A79DDQ37164209-18E7BF06-CE53-421D-B380-98999848DB5DQ37268971-1E03CC19-EE2D-4B77-B380-4FFCB158A058Q37536579-F43AAB5E-9662-43E4-A22C-D8823FD51095Q37692620-DD7DA38A-4A93-434E-9582-3C8B689D0DCFQ37697161-B8B8257E-B188-4516-9E34-21F8B18E246EQ38458426-B23339D5-A033-4702-99B5-387688A20C5DQ38584497-8A27FB02-2458-4B50-BED4-71E8B4E0A270Q38699560-6C3EE772-9649-46E8-BF1F-53A274A3318CQ38793774-9E00479B-C5CA-4119-8439-DA1937151355Q38821950-97D230CF-7150-444E-885A-06D440D0C963Q38825007-4311E836-A93B-4CFF-B24E-E7960F18F920Q39009966-1309893B-551A-47ED-AA38-7B7410B97C38Q39154029-9BBD0966-64CA-48A0-8F3B-C6B9477AEA80Q40573712-40D1E0A3-BCF7-4730-A54C-1AF9CD75574CQ40700592-F0B028F6-B254-42D2-BBB1-5D98F8F1B9F8Q41141854-597DD825-C0BB-4795-94CA-9CBF90E2FE3FQ41408442-B7206229-F190-41E5-A473-6E50BEE96451Q47101032-922C299A-A69D-400A-9240-788D7FB6D0D3Q47393672-B7B67CCC-9346-4878-855C-A36C47DB84FFQ50058751-A968127F-7D72-4FAA-95AC-9F1A81B4413FQ50276385-B58DD161-0C17-4B45-8A1B-1DEA370AB85FQ51148410-1F709871-183D-4FA3-AFE3-D980FB92D7B3Q51585030-F3AF8846-E79A-455E-BD75-E77DEEE91B6EQ52579803-8354A219-C955-4FC4-A398-5212A66E3D1CQ52669413-783AFFD9-5B6B-46E6-9F3C-A04E123F5CD0
P2860
A novel biomarker Linc00974 interacting with KRT19 promotes proliferation and metastasis in hepatocellular carcinoma.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
A novel biomarker Linc00974 in ...... s in hepatocellular carcinoma.
@ast
A novel biomarker Linc00974 in ...... s in hepatocellular carcinoma.
@en
type
label
A novel biomarker Linc00974 in ...... s in hepatocellular carcinoma.
@ast
A novel biomarker Linc00974 in ...... s in hepatocellular carcinoma.
@en
prefLabel
A novel biomarker Linc00974 in ...... s in hepatocellular carcinoma.
@ast
A novel biomarker Linc00974 in ...... s in hepatocellular carcinoma.
@en
P2093
P2860
P356
P1476
A novel biomarker Linc00974 in ...... s in hepatocellular carcinoma.
@en
P2093
P2860
P356
10.1038/CDDIS.2014.518
P577
2014-12-04T00:00:00Z